-
1
-
-
72149086102
-
Secondary attack rate of hepatitis A, varicella and mumps in household settings and reliability of family history to detect seronegative children for necessity of vaccination
-
Ceyhan M, Tezer H, Yildirim I. Secondary attack rate of hepatitis A, varicella and mumps in household settings and reliability of family history to detect seronegative children for necessity of vaccination. Scand J Infect Dis 2009;41:501-6.
-
(2009)
Scand J Infect Dis
, vol.41
, pp. 501-506
-
-
Ceyhan, M.1
Tezer, H.2
Yildirim, I.3
-
2
-
-
44849103815
-
Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
Advisory Committee on Immunization Practices Centers for Disease Control and Prevention
-
Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices Centers for Disease Control and Prevention. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57:1-30.
-
(2008)
MMWR Recomm Rep
, vol.57
, pp. 1-30
-
-
Harpaz, R.1
Ortega-Sanchez, I.R.2
Seward, J.F.3
-
3
-
-
79551676833
-
Herpes zoster recurrences more frequent than previously reported
-
Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 2011;86:88-93.
-
(2011)
Mayo Clin Proc
, vol.86
, pp. 88-93
-
-
Yawn, B.P.1
Wollan, P.C.2
Kurland, M.J.3
St Sauver, J.L.4
Saddier, P.5
-
4
-
-
0026667475
-
Herpes zoster and human immunodeficiency virus infection
-
Buchbinder SP, Katz MH, Hessol NA, Lie JY, O'Malley PM, Underwood R, et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992;166:1153-6.
-
(1992)
J Infect Dis
, vol.166
, pp. 1153-1156
-
-
Buchbinder, S.P.1
Katz, M.H.2
Hessol, N.A.3
Lie, J.Y.4
O'Malley, P.M.5
Underwood, R.6
-
5
-
-
79957735502
-
Herpes zoster in Australia: Evidence of increase in incidence in adults attributable to varicella immunization
-
Jardine A, Conaty SJ, Vally H. Herpes zoster in Australia: evidence of increase in incidence in adults attributable to varicella immunization? Epidemiol Infect 2011;139:658-65.
-
(2011)
Epidemiol Infect
, vol.139
, pp. 658-665
-
-
Jardine, A.1
Conaty, S.J.2
Vally, H.3
-
6
-
-
78149337912
-
Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine [letter]
-
Grant KA, Carville KS, Kelly HA. Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine [letter]. Med J Aust 2010;193:483.
-
(2010)
Med J Aust
, vol.193
, pp. 483
-
-
Grant, K.A.1
Carville, K.S.2
Kelly, H.A.3
-
7
-
-
56749156027
-
Herpes zosterrelated hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States
-
Patel MS, Gebremariam A, Davis MM. Herpes zosterrelated hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol 2008;29:1157-63.
-
(2008)
Infect Control Hosp Epidemiol
, vol.29
, pp. 1157-1163
-
-
Patel, M.S.1
Gebremariam, A.2
Davis, M.M.3
-
8
-
-
79955025453
-
Herpes zoster
-
ITC31-15
-
Wilson JF. Herpes zoster. Ann Intern Med 2011;154:ITC31-15.
-
(2011)
Ann Intern Med
, vol.154
-
-
Wilson, J.F.1
-
9
-
-
44649128635
-
Postherpetic neuralgia: An update on management and prevention
-
Wrigley P, Cousins MJ. Postherpetic neuralgia: an update on management and prevention. Med Today 2008;9:36-44.
-
(2008)
Med Today
, vol.9
, pp. 36-44
-
-
Wrigley, P.1
Cousins, M.J.2
-
10
-
-
67650496713
-
Antiviral treatment for preventing postherpetic neuralgia
-
Li Q, Chen N, Yang J, Zhou M, Zhou D, Zhang Q, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2009;CD006866.
-
(2009)
Cochrane Database Syst Rev
-
-
Li, Q.1
Chen, N.2
Yang, J.3
Zhou, M.4
Zhou, D.5
Zhang, Q.6
-
11
-
-
85039677824
-
-
eTG complete [internet]. Melbourne: Therapeutic Guidelines Limited
-
eTG complete [internet]. Melbourne: Therapeutic Guidelines Limited; 2010.
-
(2010)
-
-
-
12
-
-
0030913752
-
The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: A randomized, double-blind, placebo-controlled trial
-
Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 1997;13:327-31.
-
(1997)
J Pain Symptom Manage
, vol.13
, pp. 327-331
-
-
Bowsher, D.1
-
13
-
-
42449114988
-
The prevention and management of herpes zoster
-
Cunningham AL, Breuer J, Dwyer DE, Gronow DW, Helme RD, Litt JC, et al. The prevention and management of herpes zoster. Med J Aust 2008;188:171-6.
-
(2008)
Med J Aust
, vol.188
, pp. 171-176
-
-
Cunningham, A.L.1
Breuer, J.2
Dwyer, D.E.3
Gronow, D.W.4
Helme, R.D.5
Litt, J.C.6
-
14
-
-
21144448596
-
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
-
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-84.
-
(2005)
N Engl J Med
, vol.352
, pp. 2271-2284
-
-
Oxman, M.N.1
Levin, M.J.2
Johnson, G.R.3
Schmader, K.E.4
Straus, S.E.5
Gelb, L.D.6
-
15
-
-
79953280292
-
Vaccination for preventing postherpetic neuralgia
-
Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L. Vaccination for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2011;CD007795.
-
(2011)
Cochrane Database Syst Rev
-
-
Chen, N.1
Li, Q.2
Zhang, Y.3
Zhou, M.4
Zhou, D.5
He, L.6
-
16
-
-
78651505523
-
Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease
-
Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 2011;305:160-6.
-
(2011)
JAMA
, vol.305
, pp. 160-166
-
-
Tseng, H.F.1
Smith, N.2
Harpaz, R.3
Bialek, S.R.4
Sy, L.S.5
Jacobsen, S.J.6
-
17
-
-
81755178307
-
Update on herpes zoster vaccine licensure for persons aged 50 through 59 years
-
Centers for Disease Control and Prevention (CDC)
-
Harpaz R, Hales CM, Bialek SR; Centers for Disease Control and Prevention (CDC). Update on herpes zoster vaccine licensure for persons aged 50 through 59 years. MMWR Morb Mortal Wkly Rep 2011;60:1528.
-
(2011)
MMWR Morb Mortal Wkly Rep
, vol.60
, pp. 1528
-
-
Harpaz, R.1
Hales, C.M.2
Bialek, S.R.3
-
18
-
-
60249099746
-
-
9th ed, Australian Government Department of Health and Ageing. Updated 2012
-
The Australian Immunisation Handbook. 9th ed. Australian Government Department of Health and Ageing; 2008. Updated 2012. www.immunise.health.gov.au
-
(2008)
The Australian Immunisation Handbook
-
-
-
19
-
-
80052220153
-
Persistence of varicella zoster virus DNA in saliva after herpes zoster
-
Nagel MA, Choe A, Cohrs RJ, Traktinskiy I, Sorensen K, Mehta SK, et al. Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis 2011;204:820-4.
-
(2011)
J Infect Dis
, vol.204
, pp. 820-824
-
-
Nagel, M.A.1
Choe, A.2
Cohrs, R.J.3
Traktinskiy, I.4
Sorensen, K.5
Mehta, S.K.6
-
20
-
-
84867051478
-
-
Dermatology Expert Group, eTG complete [internet]. Melbourne: Therapeutic Guidelines Limited
-
Dermatology Expert Group. Therapeutic guidelines: dermatology. eTG complete [internet]. Melbourne: Therapeutic Guidelines Limited; 2010.
-
(2010)
Therapeutic guidelines: Dermatology
-
-
|